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Infectious Disease Epidemiology Report 
Invasive Methicillin-Resistant Staphylococcus aureus (MRSA) 
Maine, 2013 
  
 
 
Background 
Staphylococcus aureus, often referred to as "staph," 
are bacteria commonly found on the skin or in the 
nose of 25 - 30% of the U.S. population. This 
organism is called methicillin-sensitive 
Staphylococcus aureus (MSSA). Most of the time, 
staph do not cause any harm. Methicillin-resistant 
Staphylococcus aureus (MRSA) is a type of staph 
that is resistant to certain antibiotics called beta-
lactams. These antibiotics include methicillin and 
other more common antibiotics such as penicillin, 
amoxicillin, and oxacillin. Less than 2% of people 
in the U.S. are colonized with MRSA.  
Severe or potentially life-threatening MRSA 
infections occur most frequently among patients in 
healthcare settings with an invasive MRSA 
infection. Patients in healthcare facilities may have 
weakened immune systems, undergo procedures 
(such as surgery) or have catheters inserted into the 
skin. These conditions make it easier for MRSA to 
get into the body and infect sterile sites, such as 
blood.  
 
Methods 
An invasive MRSA infection is defined as MRSA 
isolated from a normally sterile site (blood, 
cerebrospinal fluid, pleural fluid, etc.). Common 
invasive MRSA infections include bloodstream 
infections and joint infections. Symptoms vary by 
infection location. Invasive MRSA infections are a 
reportable condition in Maine.  
 
Results 
During 2013, a total of 130 confirmed cases of 
invasive MRSA infections were reported to Maine 
CDC. This is a slight increase from the 116 cases 
reported in 2012. The rate of invasive MRSA 
infections in Maine was 9.8 cases per 100,000 
persons (Figure 1).  
 
 
 
 
 
 
 
 
 
 
Figure 1: Invasive MRSA Infection Rates in Maine, 2009-2013 
 
Sixty-one percent of invasive MRSA infections 
reported in Maine were among males. The median 
age among reported invasive MRSA infections was 
66 years (range 6 days to 96 years) (Figure 2).  
 
Figure 2: Invasive MRSA Infections by Age in Maine, 2013 
 
 
During 2013, invasive MRSA infections were 
reported in residents from all 16 counties in Maine 
(Figure 3). The rate of invasive MRSA infections 
was highest in Washington County (18.6 cases per 
100,000 residents).   Eight counties had rates of 
invasive MRSA higher than the state rate 
(Aroostook, Hancock, Kennebec, Lincoln, 
Penobscot, Piscataquis, Sagadahoc, and 
Washington). 
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Figure 3: Rate of Invasive MRSA Infections by County of 
Residence in Maine, 2013 
 
Discussion 
Maine CDC began routine surveillance for invasive 
MRSA infections in 2008 when it was added to the 
Maine CDC Notifiable Conditions List. Maine 
surveillance data for 2013 shows that rates are 
remaining relatively stable over the last five years.  
 
Although non-invasive MRSA is not reportable, the 
best way to prevent invasive MRSA is to prevent 
non-invasive MRSA, including skin and soft tissue 
infections. 
 
The most significant risk factor for MRSA infection 
is open wounds or broken skin, such as a surgical 
site. However, MRSA infections can occur on areas 
of the skin where there is no obvious wound or 
break in the skin. 
 
Preventive measures to reduce MRSA transmission: 
• Cover wounds with clean, dry bandages 
until healed 
• Do not attempt to treat a MRSA skin 
infection by yourself; doing so could worsen 
or spread it to others 
• Wash hands with soap and water or use an 
alcohol-based hand rub to prevent the spread 
of MRSA 
• Use disinfectants effective against 
Staphylococcus aureus 
• Avoid sharing personal items including 
towels, washcloths, razors, and clothing 
• Avoid contact sports and other skin-to-skin 
contact until your infection has healed 
 
Invasive MRSA infections and all outbreaks of 
MRSA are reportable to Maine CDC by calling 1-
800-821-5821 or faxing to 1-800-293-7534. MRSA 
infections that are acquired from a healthcare 
facility are reportable to the National Healthcare 
Safety Network, a federal CDC surveillance system. 
For more information contact your healthcare 
provider.   
 
Additional information about MRSA infections is 
available at: 
• Maine CDC 
website: http://www.maine.gov/dhhs/mecdc/
infectious-disease/epi/airborne/mrsa.shtml 
• Federal CDC 
website: http://www.cdc.gov/mrsa/ 
 
